# Study of Valproic Acid to Treat HIV Infected Adults

> **NCT00312546** · PHASE1 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 14 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Enfuvirtide
- **DRUG:** Valproic acid

## Key facts

- **NCT ID:** NCT00312546
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2009-04
- **Final completion:** 2009-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312546, "Study of Valproic Acid to Treat HIV Infected Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00312546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*